Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) is -48.90% lower on its value in year-to-date trading and has touched a low of $4.64 and a high of $61.90 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CRBP stock was last observed hovering at around $5.92 in the last trading session, with the day’s gains setting it 0.11%.
Currently trading at $6.03, the stock is 7.43% and -12.00% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.12 million and changing 1.86% at the moment leaves the stock -75.39% off its SMA200. CRBP registered -85.34% loss for a year compared to 6-month loss of -68.04%. The firm has a 50-day simple moving average (SMA 50) of $6.8522 and a 200-day simple moving average (SMA200) of $24.50325.
The stock witnessed a 0.00% gain in the last 1 month and extending the period to 3 months gives it a -54.04%, and is 5.98% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.07% over the week and 7.83% over the month.
Corbus Pharmaceuticals Holdings Inc (CRBP) has around 28 employees, a market worth around $73.76M and $0.00M in sales. Distance from 52-week low is 29.96% and -90.26% from its 52-week high. The company has generated returns on investments over the last 12 months (-27.91%).
The EPS is expected to shrink by -35.66% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
143.0 institutions hold shares in Corbus Pharmaceuticals Holdings Inc (CRBP), with institutional investors hold 98.70% of the company’s shares. The shares outstanding are 12.18M, and float is at 10.55M with Short Float at 23.43%. Institutions hold 98.20% of the Float.
Corbus Pharmaceuticals Holdings Inc (CRBP) Insider Activity
The most recent transaction is an insider sale by Smethurst Dominic, the company’s Chief Medical Officer. SEC filings show that Smethurst Dominic sold 6,393 shares of the company’s common stock on Mar 06 ’25 at a price of $6.78 per share for a total of $43330.0. Following the sale, the insider now owns 70807.0 shares.
Still, SEC filings show that on Feb 14 ’25, Moran Sean F. (Chief Financial Officer) disposed off 2,792 shares at an average price of $8.76 for $24446.0. The insider now directly holds 73,313 shares of Corbus Pharmaceuticals Holdings Inc (CRBP).
